World Cancer Day aims to prevent millions of deaths each year by raising awareness and education about cancer, and pressing governments and individuals across the world to take action against the disease. We strongly support this initiative led by the Union for International Cancer Control (UICC).
Aniling is aware of the impact of cancer in society and its main objective is focused on the development of a diagnostic pipeline for patient journey improvement. Our first certified product, GEUS-CLL, is a diagnostic kit for chronic lymphocytic leukemia patients that integrates all the genetic and epigenetic information in a single test, selecting the best treatment at the beginning, reducing unnecessary treatments and improving patient quality of life.
Aniling is committed to making precision medicine against cancer a reality.